Department of Physiology, Anatomy, and Microbiology, La Trobe University, Melbourne, VIC 3086, Australia.
National Centre for Epidemiology and Population Health, Research School of Population Health, Australian National University, Canberra, ACT 2601, Australia.
Int J Mol Sci. 2020 Feb 6;21(3):1074. doi: 10.3390/ijms21031074.
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is an enigmatic condition characterized by exacerbation of symptoms after exertion (post-exertional malaise or "PEM"), and by fatigue whose severity and associated requirement for rest are excessive and disproportionate to the fatigue-inducing activity. There is no definitive molecular marker or known underlying pathological mechanism for the condition. Increasing evidence for aberrant energy metabolism suggests a role for mitochondrial dysfunction in ME/CFS. Our objective was therefore to measure mitochondrial function and cellular stress sensing in actively metabolizing patient blood cells. We immortalized lymphoblasts isolated from 51 ME/CFS patients diagnosed according to the Canadian Consensus Criteria and an age- and gender-matched control group. Parameters of mitochondrial function and energy stress sensing were assessed by Seahorse extracellular flux analysis, proteomics, and an array of additional biochemical assays. As a proportion of the basal oxygen consumption rate (OCR), the rate of ATP synthesis by Complex V was significantly reduced in ME/CFS lymphoblasts, while significant elevations were observed in Complex I OCR, maximum OCR, spare respiratory capacity, nonmitochondrial OCR and "proton leak" as a proportion of the basal OCR. This was accompanied by a reduction of mitochondrial membrane potential, chronically hyperactivated TOR Complex I stress signaling and upregulated expression of mitochondrial respiratory complexes, fatty acid transporters, and enzymes of the β-oxidation and TCA cycles. By contrast, mitochondrial mass and genome copy number, as well as glycolytic rates and steady state ATP levels were unchanged. Our results suggest a model in which ME/CFS lymphoblasts have a Complex V defect accompanied by compensatory upregulation of their respiratory capacity that includes the mitochondrial respiratory complexes, membrane transporters and enzymes involved in fatty acid β-oxidation. This homeostatically returns ATP synthesis and steady state levels to "normal" in the resting cells, but may leave them unable to adequately respond to acute increases in energy demand as the relevant homeostatic pathways are already activated.
肌痛性脑脊髓炎/慢性疲劳综合征(ME/CFS)是一种神秘的病症,其特征是在活动后(活动后不适或“PEM”)症状加重,以及疲劳的严重程度和相关的休息需求与引起疲劳的活动不成比例。目前尚无该疾病明确的分子标志物或已知的潜在病理机制。越来越多的证据表明,异常的能量代谢与 ME/CFS 有关。因此,我们的目标是测量活跃代谢的患者血细胞中的线粒体功能和细胞应激感应。我们从根据加拿大共识标准诊断为 ME/CFS 的 51 名患者和年龄、性别匹配的对照组中分离出淋巴母细胞,并对其进行永生化。通过 Seahorse 细胞外通量分析、蛋白质组学和一系列额外的生化测定来评估线粒体功能和能量应激感应的参数。与基础耗氧量(OCR)相比,ME/CFS 淋巴母细胞中由复合物 V 合成的 ATP 速率显著降低,而复合物 I OCR、最大 OCR、备用呼吸能力、非线粒体 OCR 和“质子泄漏”(占基础 OCR 的比例)则显著升高。这伴随着线粒体膜电位的降低、慢性过度激活的 TOR 复合物 I 应激信号和线粒体呼吸复合物、脂肪酸转运蛋白以及β-氧化和 TCA 循环的酶的上调表达。相比之下,线粒体质量和基因组拷贝数以及糖酵解速率和稳态 ATP 水平保持不变。我们的研究结果表明,ME/CFS 淋巴母细胞存在复合物 V 缺陷,伴有其呼吸能力的代偿性上调,其中包括线粒体呼吸复合物、膜转运蛋白和参与脂肪酸β-氧化的酶。这使 ATP 合成和静止细胞中的稳态水平恢复到“正常”,但可能使它们无法充分应对急性能量需求增加,因为相关的稳态途径已经被激活。